相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides
Paola Filipazzi et al.
CLINICAL CANCER RESEARCH (2012)
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy
Yann Godet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression
Veronique Decot et al.
EXPERIMENTAL HEMATOLOGY (2010)
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes
Regis Bouquie et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones
Amir Khammari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
CD25 Blockade protects T Cells from Activation-induced Cell Death (AICD) via Maintenance of TOSO Expression
G. H. S. Richter et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency
Yann Godet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting
Nathalie Labarriere et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
Amir Khammari et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients
Houssem Benlalam et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma
Andreas Mackensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor antigen expression in melanoma varies according to antigen and stage
C Barrow et al.
CLINICAL CANCER RESEARCH (2006)
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells
V Vignard et al.
JOURNAL OF IMMUNOLOGY (2005)
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients
N Meidenbauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients
N Labarrière et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
B Dréno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L:: a qualitative analysis
B Palermo et al.
MELANOMA RESEARCH (2002)
Thymic selection generates a large T cell pool recognizing a self-peptide in humans
A Zippelius et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding
M Bodinier et al.
NATURE MEDICINE (2000)
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue
D Valmori et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
